Difference between revisions of "MDAI"

From DMT-Nexus Wiki
Jump to: navigation, search
Line 7: Line 7:
 
* Nausea, headache, tiredness, depression, rise in blood pressure
 
* Nausea, headache, tiredness, depression, rise in blood pressure
 
|
 
|
* Mental addiction. WARNING: Some studies have shown that much of what is sold online as "MDAI" actually contains other drugs such as mephedrone.
+
* Mental addiction. WARNING: Some studies have shown that much of what is sold online as "MDAI" actually contains mephedrone and/or other drugs.
 
|
 
|
 
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!
 
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!

Revision as of 22:24, 19 December 2013

Safety profile Note error.png
Category:
  • Entactogen, Empathogen, SSRA
Main effects:
  • Entactogenic effects, Empathogenic effects, Euphoria
Side effects:
  • Nausea, headache, tiredness, depression, rise in blood pressure
Health risks:
  • Mental addiction. WARNING: Some studies have shown that much of what is sold online as "MDAI" actually contains mephedrone and/or other drugs.
Important safety remarks:
  • Cardiovascular toxicity has not been tested. As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!


Brief overview - What is MDAI?

5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA). Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.